Influence of translation efficiency of homologous viral proteins on the endogenous presentation of CD8+ T cell epitopes
Open Access
- 20 February 2007
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 204 (3) , 525-532
- https://doi.org/10.1084/jem.20062508
Abstract
A significant proportion of endogenously processed CD8+ T cell epitopes are derived from newly synthesized proteins and rapidly degrading polypeptides (RDPs). It has been hypothesized that the generation of rapidly degrading polypeptides and CD8+ T cell epitopes from these RDP precursors may be influenced by the efficiency of protein translation. Here we address this hypothesis by using the Epstein-Barr virus–encoded nuclear antigen 1 protein (EBNA1), with or without its internal glycine-alanine repeat sequence (EBNA1 and EBNA1ΔGA, respectively), which display distinct differences in translation efficiency. We demonstrate that RDPs constitute a significant proportion of newly synthesized EBNA1 and EBNA1ΔGA and that the levels of RDPs produced by each of these proteins directly correlate with the translation efficiency of either EBNA1 or EBNA1ΔGA. As a consequence, a higher number of major histocompatibility complex–peptide complexes can be detected on the surface of cells expressing EBNA1ΔGA, and these cells are more efficiently recognized by virus-specific cytotoxic T lymphocytes compared to the full-length EBNA1. More importantly, we also demonstrate that the endogenous processing of these CD8+ T cell epitopes is predominantly determined by the rate at which the RDPs are generated rather than the intracellular turnover of these proteins.Keywords
This publication has 38 references indexed in Scilit:
- UNDERSTANDING PRESENTATION OF VIRAL ANTIGENS TO CD8+T CELLS IN VIVO: The Key to Rational Vaccine DesignAnnual Review of Immunology, 2005
- Endogenous Presentation of CD8+ T Cell Epitopes from Epstein-Barr Virus–encoded Nuclear Antigen 1The Journal of Experimental Medicine, 2004
- CD8 T Cell Recognition of Endogenously Expressed Epstein-Barr Virus Nuclear Antigen 1The Journal of Experimental Medicine, 2004
- Self-Inhibition of Synthesis and Antigen Presentation by Epstein-Barr Virus-Encoded EBNA1Science, 2003
- Producing Nature’s Gene-Chips: The Generation of Peptides for Display by MHC Class I MoleculesAnnual Review of Immunology, 2002
- Targeting of EBNA1 for Rapid Intracellular Degradation Overrides the Inhibitory Effects of the Gly-Ala Repeat Domain and Restores CD8+ T Cell RecognitionJournal of Biological Chemistry, 2001
- Role of Cytotoxic T Lymphocytes in Epstein-Barr Virus-Associated DiseasesAnnual Review of Microbiology, 2000
- Overexpression of an epitope‐ tagged β‐tubulin in Chinese hamster ovary cells causes an increase in endogenous α‐tubulin synthesisCell Motility, 1995
- Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.The Journal of Experimental Medicine, 1992
- Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line.The Journal of cell biology, 1988